Author:
Savic S,Tapia C,Grilli B,Rufle A,Bihl M P,de Vito Barascud A,Herzog M,Terracciano L,Baty F,Bubendorf L
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Arteaga CL (2002) Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia. Semin Oncol 29: 3–9
2. Bell DW, Lynch TJ, Haserlat SM, Harris PL, Okimoto RA, Brannigan BW, Sgroi DC, Muir B, Riemenschneider MJ, Iacona RB, Krebs AD, Johnson DH, Giaccone G, Herbst RS, Manegold C, Fukuoka M, Kris MG, Baselga J, Ochs JS, Haber DA (2005) Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials. J Clin Oncol 23: 8081–8092
3. Berezuk M, West J, Varella-Garcia M, Franklin WA (2001) Adjusting interphase FISH results in epithelial tissue sections to whole cell complement. Anal Quant Cytol Histol 23: 93–100
4. Bozzetti C, Nizzoli R, Guazzi A, Flora M, Bassano C, Crafa P, Naldi N, Cascinu S (2002) HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer. Ann Oncol 13: 1398–1403
5. Cappuzzo F, Finocchiaro G, Metro G, Bartolini S, Magrini E, Cancellieri A, Trisolini R, Castaldini L, Tallini G, Crino L (2006) Clinical experience with gefitinib: an update. Crit Rev Oncol Hematol 58: 31–45
Cited by
91 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献